Leonardo Gomes da Fonseca

Statistics

Publications

Citations

945

H-Index

Active since

2014

Affiliations

Instituto do Câncer do Estado de São Paulo(Current)

Universidade de São Paulo

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Universitat de Barcelona

Leonardo Gomes da Fonseca is an author at Instituto do Câncer do Estado de São Paulo specializing in medicine, oncology, and hepatocellular carcinoma.

ORCID

Publications per year

2014–2025

Publications

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Thomas Yau, Peter R. Galle, Thomas Decaens et al. · The Lancet · 2025 · 270 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

Manuel de la Torre‐Aláez, Ana Matilla, Marı́a Varela et al. · Journal for ImmunoTherapy of Cancer · 2022 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Sergio Muñoz, Víctor Sapena, Alejandro Forner et al. · JHEP Reports · 2021 · 67 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes

Ricardo Emanuel de Oliveira Ramos, Milena Perez Mak, Michel Alves et al. · Journal of Global Oncology · 2017 · 50 citations · Full text

Medicine, Oncology, Pharmacology +15

Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Leonardo Gomes da Fonseca, Romualdo Barroso‐Sousa, Afonso da Silva Alves Bento et al. · Medical Oncology · 2014 · 45 citations

Medicine, Hematology, Oncology +13

1–5 of 26